Here is a thorough, evidence-based summary of metformin management around surgery, covering both the pre-op hold and post-op restart.
Metformin - Perioperative Management & Post-Surgery Restart
Why Metformin Is Held
Metformin does not cause hypoglycemia directly, but the concern is metformin-associated lactic acidosis (MALA). This risk is amplified when:
- Hemodynamic instability, hypotension, or poor tissue perfusion occurs (common during surgery/anesthesia)
- Renal perfusion is reduced (dehydration, contrast agents, blood loss)
- The patient is NPO and unable to maintain adequate hydration
Surgical stress impairs these compensatory mechanisms, creating a window of elevated risk even though MALA is statistically uncommon in patients with normal renal function. - Barash Clinical Anesthesia, 9e, p. 4044; Sabiston Textbook of Surgery, p. 1435
Pre-Op: When to Stop Metformin
| Surgery Type | Recommendation |
|---|
| Minor/outpatient, local anaesthesia, no contrast | May continue - individualize; assess renal function |
| Elective surgery under GA/regional, normal eGFR (>60) | Hold morning-of-surgery dose only (not 48 hours before) |
| Procedure with iodinated contrast, eGFR 30-60 | Hold at time of procedure |
| eGFR <30 or acute kidney injury | Hold earlier; seek specialist advice |
Key shift in guidance: The old practice of stopping metformin 48 hours
before surgery is no longer recommended for most patients.
Current ADA 2024 guidance supports holding only the day-of-surgery dose for patients with eGFR >60, avoiding the unnecessary hyperglycemia that prolonged pre-op holds cause.
A
2024 narrative review of 10 perioperative metformin guidelines (2015-2024) found 7/10 support
continuing metformin in patients without risk factors, with withholding only on the morning of surgery when risk factors are present.
Post-Op: When to Restart Metformin
The restart decision depends on three conditions being met simultaneously:
- Oral intake restored - patient is tolerating food and fluids normally
- Renal function confirmed stable - serum creatinine back to baseline (not just "normal range" - compare to pre-op value)
- Hemodynamically stable - no ongoing hypotension, shock, or sepsis
| Clinical scenario | Restart timing |
|---|
| Minor surgery, normal eGFR, eating same day | Can restart same day or next day |
| Major elective surgery, normal pre-op renal function, eating by day 2 | 48 hours post-op, once creatinine confirmed at baseline |
| Contrast used (eGFR 30-60) | 48 hours post-op minimum, two stable creatinine readings |
| eGFR <30, or AKI developed post-op | Hold until renal function stabilises - seek diabetes specialist input |
| Post-bariatric surgery (gastric bypass) | Restart from day 3 post-op; switch MR/SR formulations to immediate-release; dose may need reduction due to increased bioavailability |
| eGFR >60 - UKCPA Perioperative Handbook | Restart without delay once eating and haemodynamically stable |
Practical Notes
- Blood glucose monitoring is essential while metformin is held - patients will need temporary insulin or alternative coverage
- SGLT2 inhibitors (co-prescribed in many T2DM patients) must be stopped 3-4 days before surgery separately due to euglycaemic DKA risk
- Sulfonylureas should also be held due to hypoglycaemia risk during fasting - do not restart until eating reliably
- HbA1c <8% is a commonly accepted threshold before elective surgery - Sabiston, p. 1424
- Post-bariatric surgery patients need special consideration: bioavailability of metformin increases after gastric bypass, so immediate-release formulations at reduced doses are preferred
Summary
Hold metformin on the day of surgery (not days before, unless eGFR is reduced). Restart it post-operatively once the patient is eating, haemodynamically stable, and creatinine is confirmed back to baseline - typically at or around 48 hours after major surgery, or sooner after minor procedures. The 48-hour window is a minimum checkpoint for renal function reassessment, not a mandatory delay in all cases.